{"identifier":"/us/usc/t21/s1714","title_num":"21","num":"§ 1714.","heading":"Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions","status":null,"guid":"id14cfb2bc-3a70-11f1-b089-c1e1e512a22d","source_credit":"(Pub. L. 105–277, div. C, title VII, § 716, as added Pub. L. 109–469, title XI, § 1119, Dec. 29, 2006, 120 Stat. 3547; amended Pub. L. 105–277, div. C. title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, § 8202(a), (b)(2), Oct. 24, 2018, 132 Stat. 4110.)","seq_in_title":686,"parent_identifier":"/us/usc/t21/ch22","ancestors":[{"identifier":"/us/usc/t21","level":"title","num":"Title 21—","heading":"FOOD AND DRUGS","status":null,"is_section":false},{"identifier":"/us/usc/t21/ch22","level":"chapter","num":"CHAPTER 22—","heading":"NATIONAL DRUG CONTROL POLICY","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"id7df9593c-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714\"><num value=\"1714\">§ 1714.</num><heading> Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions</heading><subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7df9593d-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/a\"><num value=\"a\" class=\"bold\">(a)</num><heading class=\"bold\"> Awards required</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">The Director shall make competitive awards to fund demonstration programs by eligible partnerships for the purpose of reducing the use of illicit drugs by chronic hard-drug users living in the community while under the supervision of the criminal justice system.</p>\n</content>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7df9593e-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/b\"><num value=\"b\" class=\"bold\">(b)</num><heading class=\"bold\"> Use of award amounts</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">Award amounts received under this section shall be used—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df9593f-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/b/1\"><num value=\"1\">(1)</num><content> to support the efforts of the agencies, organizations, and researchers included in the eligible partnership;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df95940-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/b/2\"><num value=\"2\">(2)</num><content> to develop and field a drug testing and graduated sanctions program for chronic hard-drug users living in the community under criminal justice supervision; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df95941-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/b/3\"><num value=\"3\">(3)</num><content> to assist individuals described in subsection (a) by strengthening rehabilitation efforts through such means as job training, drug treatment, or other services.</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7df98052-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c\"><num value=\"c\" class=\"bold\">(c)</num><heading class=\"bold\"> Eligible partnership defined</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">In this section, the term “eligible partnership” means a working group whose application to the Director—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df98053-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/1\"><num value=\"1\">(1)</num><chapeau> identifies the roles played, and certifies the involvement of, two or more agencies or organizations, which may include—</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7df98054-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/1/A\"><num value=\"A\">(A)</num><content> State, local, or tribal agencies (such as those carrying out police, probation, prosecution, courts, corrections, parole, or treatment functions);</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7df98055-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/1/B\"><num value=\"B\">(B)</num><content> Federal agencies (such as the Drug Enforcement Agency, the Bureau of Alcohol, Tobacco, Firearms, and Explosives, and United States Attorney offices); and</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"id7df98056-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/1/C\"><num value=\"C\">(C)</num><content> community-based organizations;</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df98057-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/2\"><num value=\"2\">(2)</num><content> includes a qualified researcher;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df98058-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/3\"><num value=\"3\">(3)</num><content> includes a plan for using judicial or other criminal justice authority to administer drug tests to individuals described in subsection (a) at least twice a week, and to swiftly and certainly impose a known set of graduated sanctions for non-compliance with community-release provisions relating to drug abstinence (whether imposed as a pre-trial, probation, or parole condition or otherwise);</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df98059-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/4\"><num value=\"4\">(4)</num><content> includes a strategy for responding to a range of substance use and abuse problems and a range of criminal histories;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df9805a-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/5\"><num value=\"5\">(5)</num><content> includes a plan for integrating data infrastructure among the agencies and organizations included in the eligible partnership to enable seamless, real-time tracking of individuals described in subsection (a);</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"id7df9805b-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/c/6\"><num value=\"6\">(6)</num><content> includes a plan to monitor and measure the progress toward reducing the percentage of the population of individuals described in subsection (a) who, upon being summoned for a drug test, either fail to show up or who test positive for drugs.</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7df9805c-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/d\"><num value=\"d\" class=\"bold\">(d)</num><heading class=\"bold\"> Reports to Congress</heading><paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id7df9a76d-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/d/1\"><num value=\"1\" class=\"bold\">(1)</num><heading class=\"bold\"> Interim report</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">Not later than <date date=\"2009-06-01\">June 1, 2009</date>, the Director shall submit to Congress a report that identifies the best practices in reducing the use of illicit drugs by chronic hard-drug users, including the best practices identified through the activities funded under this section.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"id7df9a76e-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/d/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> Final report</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">Not later than <date date=\"2010-06-01\">June 1, 2010</date>, the Director shall submit to Congress a report on the demonstration programs funded under this section, including on the matters specified in paragraph (1).</p>\n</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"id7df9a76f-81bc-11eb-b838-b6993269d559\" identifier=\"/us/usc/t21/s1714/e\"><num value=\"e\" class=\"bold\">(e)</num><heading class=\"bold\"> Authorization of appropriations</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">There is authorized to be appropriated to carry out this section $4,900,000 for each of fiscal years 2007 through 2009.</p>\n</content>\n</subsection>\n<sourceCredit id=\"id7df9a770-81bc-11eb-b838-b6993269d559\">(<ref href=\"/us/pl/105/277/dC/tVII/s716\">Pub. L. 105–277, div. C, title VII, § 716</ref>, as added <ref href=\"/us/pl/109/469/tXI/s1119\">Pub. L. 109–469, title XI, § 1119</ref>, <date date=\"2006-12-29\">Dec. 29, 2006</date>, <ref href=\"/us/stat/120/3547\">120 Stat. 3547</ref>; amended <ref href=\"/us/pl/105/277/dC\">Pub. L. 105–277, div. C</ref>. title VII, § 715, <date date=\"1998-10-21\">Oct. 21, 1998</date>, <ref href=\"/us/stat/112/2681-693\">112 Stat. 2681–693</ref>; <ref href=\"/us/pl/109/469/tVI/s602\">Pub. L. 109–469, title VI, § 602</ref>, <date date=\"2006-12-29\">Dec. 29, 2006</date>, <ref href=\"/us/stat/120/3533\">120 Stat. 3533</ref>; <ref href=\"/us/pl/115/271/tVIII/s8202/a\">Pub. L. 115–271, title VIII, § 8202(a)</ref>, (b)(2), <date date=\"2018-10-24\">Oct. 24, 2018</date>, <ref href=\"/us/stat/132/4110\">132 Stat. 4110</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"id7df9a771-81bc-11eb-b838-b6993269d559\">\n<note style=\"-uslm-lc:I74\" role=\"crossHeading\" topic=\"editorialNotes\" id=\"id7df9a772-81bc-11eb-b838-b6993269d559\"><heading class=\"centered\"><b>Editorial Notes</b></heading></note>\n<note style=\"-uslm-lc:I74\" topic=\"amendments\" id=\"id7df9a773-81bc-11eb-b838-b6993269d559\"><heading class=\"centered smallCaps\">Amendments</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">2018—<ref href=\"/us/pl/115/271/s8202/b/2\">Pub. L. 115–271, § 8202(b)(2)</ref>, repealed <ref href=\"/us/pl/105/277/s715\">Pub. L. 105–277, § 715</ref>. See 1998 Amendment note below.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\"><ref href=\"/us/pl/115/271/s8202/a\">Pub. L. 115–271, § 8202(a)</ref>, revived and restored this section as in effect on <date date=\"2003-09-29\">Sept. 29, 2003</date>, and as amended by <ref href=\"/us/pl/109/469\">Pub. L. 109–469</ref> and <ref href=\"/us/pl/112/166\">Pub. L. 112–166</ref>. See Reauthorization of the Office of National Drug Control Policy note set out under <ref href=\"/us/usc/t21/s1701\">section 1701 of this title</ref>.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">2006—<ref href=\"/us/pl/109/469\">Pub. L. 109–469</ref> amended <ref href=\"/us/pl/105/277/s715\">Pub. L. 105–277, § 715</ref>, which provided for the repeal of this section. See 1998 Amendment note below.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">1998—<ref href=\"/us/pl/105/277/s715\">Pub. L. 105–277, § 715</ref>, as amended by <ref href=\"/us/pl/109/469/s602\">Pub. L. 109–469, § 602</ref>, which provided for the repeal of this section effective <date date=\"2010-09-30\">Sept. 30, 2010</date>, was repealed by <ref href=\"/us/pl/115/271/s8202/b/2\">Pub. L. 115–271, § 8202(b)(2)</ref>. See former <ref href=\"/us/usc/t21/s1712\">section 1712 of this title</ref>.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"119-83","currency_date":"2026-04-13","congress":119,"law_num":83,"excluded_laws":[],"update_num":null,"seq":371,"is_partial":false,"caveat":null,"titles_affected":["01","02","05","06","07","08","10","11","12","15","16","18","19","20","21","22","23","26","28","29","30","31","33","34","36","38","40","41","42","43","48","49","50","51","54"],"ingested_titles":[]},"served_from":{"label":"119-83","currency_date":"2026-04-13","congress":119,"law_num":83,"excluded_laws":[],"update_num":null,"seq":371,"is_partial":false,"caveat":null,"titles_affected":["01","02","05","06","07","08","10","11","12","15","16","18","19","20","21","22","23","26","28","29","30","31","33","34","36","38","40","41","42","43","48","49","50","51","54"],"ingested_titles":[]},"content_first_seen":{"label":"116-314not260not283","currency_date":"2021-01-05","congress":116,"law_num":314,"excluded_laws":[260,283],"update_num":null,"seq":225,"is_partial":true,"caveat":"Current through Public Law 116-314 (01/05/2021), except 116-260, 116-283.","titles_affected":["05","05a","06","15","16","18","21","25","28","31","33","34","42","50","54"],"ingested_titles":[]},"is_exact":true,"note":null}